These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27893713)

  • 41. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RSK2 mediates muscle cell differentiation through regulation of NFAT3.
    Cho YY; Yao K; Bode AM; Bergen HR; Madden BJ; Oh SM; Ermakova S; Kang BS; Choi HS; Shim JH; Dong Z
    J Biol Chem; 2007 Mar; 282(11):8380-92. PubMed ID: 17213202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
    Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
    Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NFAT transcription factors: from cell cycle to tumor development.
    Viola JP; Carvalho LD; Fonseca BP; Teixeira LK
    Braz J Med Biol Res; 2005 Mar; 38(3):335-44. PubMed ID: 15761612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deregulated expression of CDK2- or CDK3-associated kinase activities enhances c-Myc-induced apoptosis.
    Braun K; Hölzl G; Pusch O; Hengstschläger M
    DNA Cell Biol; 1998 Sep; 17(9):789-98. PubMed ID: 9778038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ha-ras oncogene-induced Stat3 phosphorylation enhances oncogenicity of the cell.
    Yeh HH; Giri R; Chang TY; Chou CY; Su WC; Liu HS
    DNA Cell Biol; 2009 Mar; 28(3):131-9. PubMed ID: 19182994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
    Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
    Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxysterol-binding protein-related protein 4L promotes cell proliferation by sustaining intracellular Ca2+ homeostasis in cervical carcinoma cell lines.
    Li JW; Xiao YL; Lai CF; Lou N; Ma HL; Zhu BY; Zhong WB; Yan DG
    Oncotarget; 2016 Oct; 7(40):65849-65861. PubMed ID: 27588468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
    Sato M; Vaughan MB; Girard L; Peyton M; Lee W; Shames DS; Ramirez RD; Sunaga N; Gazdar AF; Shay JW; Minna JD
    Cancer Res; 2006 Feb; 66(4):2116-28. PubMed ID: 16489012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of Rac1 in maintaining malignant phenotype of mouse skin tumor cells.
    Kwei KA; Finch JS; Ranger-Moore J; Bowden GT
    Cancer Lett; 2006 Jan; 231(2):326-38. PubMed ID: 15893875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells.
    Bhatt S; Stender JD; Joshi S; Wu G; Katzenellenbogen BS
    Oncogene; 2016 Nov; 35(44):5722-5734. PubMed ID: 27065334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation.
    Cho YY; Yao K; Kim HG; Kang BS; Zheng D; Bode AM; Dong Z
    Cancer Res; 2007 Sep; 67(17):8104-12. PubMed ID: 17804722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling.
    Xu H; Sun H; Zhang H; Liu J; Fan F; Li Y; Ning X; Sun Y; Dai S; Liu B; Gao M; Fu S; Zhou C
    PLoS One; 2015; 10(5):e0124033. PubMed ID: 25962159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors.
    Robbs BK; Cruz AL; Werneck MB; Mognol GP; Viola JP
    Mol Cell Biol; 2008 Dec; 28(23):7168-81. PubMed ID: 18809576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
    Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C
    Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Expression and significance of COX-2 and its transcription factors NFAT3 and c-Jun in non-small cell lung cancer].
    Zhao X; Chen Z; Zhao S; He J
    Zhongguo Fei Ai Za Zhi; 2010 Nov; 13(11):1035-40. PubMed ID: 21081043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An overview of CDK3 in cancer: clinical significance and pharmacological implications.
    Teo T; Kasirzadeh S; Albrecht H; Sykes MJ; Yang Y; Wang S
    Pharmacol Res; 2022 Jun; 180():106249. PubMed ID: 35533805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RSK2 as a key regulator in human skin cancer.
    Cho YY; Lee MH; Lee CJ; Yao K; Lee HS; Bode AM; Dong Z
    Carcinogenesis; 2012 Dec; 33(12):2529-37. PubMed ID: 22918890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Essential role of ROS-mediated NFAT activation in TNF-alpha induction by crystalline silica exposure.
    Ke Q; Li J; Ding J; Ding M; Wang L; Liu B; Costa M; Huang C
    Am J Physiol Lung Cell Mol Physiol; 2006 Aug; 291(2):L257-64. PubMed ID: 16489119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcription factor NFAT, its role in cancer development, and as a potential target for chemoprevention.
    Lu H; Huan C
    Curr Cancer Drug Targets; 2007 Jun; 7(4):343-53. PubMed ID: 17979629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.